Bicara Therapeutics BCAX Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Bicara Therapeutics (BCAX) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -22.9% in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- This metric measures the percentage change in the valuation allowance for deferred tax assets relative to the statutory tax rate. It reflects management's assessment of the likelihood that the company will generate sufficient future taxable income to realize its deferred tax assets. Significant fluctuations can indicate changes in the company's long-term profitability outlook.